> Markdown version of https://haygoodhealth.com/c/payment-incentives for AI agents. You are welcome here, and welcome back anytime. What an agent can do: https://haygoodhealth.com/agents . # Payment incentives - Haygood Health A knowledge clinic for families [Haygood Health](/) [← Haygood Health](/) ### [Payment incentives](/c/payment-incentives) MechanismN/AOutcomeD Claimed Hospital payment rules (the COVID-19 diagnosis add-on, self-pay labeling) changed the care individual patients received. What holds up This is a health-policy incentive claim, not a biological mechanism claim, so the mechanism axis does not apply (per the brief). Section 3710 of the CARES Act (P.L. 116-136) directed the HHS Secretary to increase the MS-DRG weight by 20% for Medicare discharges diagnosed with COVID-19 during the public health emergency, and CMS required a positive viral test in the record for admissions on or after September 1, 2020. The HHS OIG's December 2023 audit of $2.7 billion in such payments found 146 of 149 sampled claims complied with federal requirements, with 3 failures ($18,911) attributed to clerical errors. The OIG itself acknowledged hospitals "may have had a financial incentive" to code COVID-19, and cited then-CDC Director Redfield's July 2020 House testimony that there was "some reality" to diagnosis-preference billing. What it does not show The incentive structure is documented fact, but no published study tests whether the add-on changed any individual patient's treatment; the one systematic official review (HHS OIG) examined billing compliance only and found no pattern of improper coding. That the add-on changed the care any individual patient received. The OIG audit tested whether coding and billing met federal requirements, not whether payment influenced intubation, drug, or comfort-care decisions, and it found no pattern of improper COVID-19 coding. No claims-based analysis links the 20% add-on to treatment intensity or outcomes. Association (the incentive existed and was publicly acknowledged) is not proof of altered care. On the self-pay labeling question: CMS's EMTALA page confirms Section 1867 of the Social Security Act obligates Medicare-participating hospitals to provide a medical screening examination and stabilizing treatment regardless of ability to pay, which constrains but does not eliminate downstream effects of self-pay coding; no evidence was found that self-pay coding changed COVID treatment decisions. Evidence for HHS Office of Inspector General, December 2023, Report A-09-21-03009, Centers for Medicare and Medicaid Services, EMTALA page, citing SSA section 1867, cms.gov, Congressional Research Service, R46334, "Selected Health Provisions in Title III of the CARES Act," congress.gov Sources VERIFIED HHS Office of Inspector General, December 2023, Report A-09-21-03009. VERIFIED Centers for Medicare and Medicaid Services, EMTALA page, citing SSA section 1867, cms.gov. PENDING Congressional Research Service, R46334, "Selected Health Provisions in Title III of the CARES Act," congress.gov. ## Grade history (append-only) Every grade change is kept, never overwritten, so the current grade and every prior one stay visible. Mechanism gradeJustificationGraded byStateGraded at N/AThis is a health-policy incentive claim, not a biological mechanism claim, so the mechanism axis does not apply (per the brief). Section 3710 of the CARES Act (P.L. 116-136) directed the HHS Secretary to increase the MS-DRG weight by 20% for Medicare discharges diagnosed with COVID-19 during the public health emergency, and CMS required a positive viral test in the record for admissions on or after September 1, 2020. The HHS OIG's December 2023 audit of $2.7 billion in such payments found 146 of 149 sampled claims complied with federal requirements, with 3 failures ($18,911) attributed to clerical errors. The OIG itself acknowledged hospitals "may have had a financial incentive" to code COVID-19, and cited then-CDC Director Redfield's July 2020 House testimony that there was "some reality" to diagnosis-preference billing.admindisplayed2026-10-08T23:52:30.459Z Outcome gradeJustificationGraded byStateGraded at DThe incentive structure is documented fact, but no published study tests whether the add-on changed any individual patient's treatment; the one systematic official review (HHS OIG) examined billing compliance only and found no pattern of improper coding. That the add-on changed the care any individual patient received. The OIG audit tested whether coding and billing met federal requirements, not whether payment influenced intubation, drug, or comfort-care decisions, and it found no pattern of improper COVID-19 coding. No claims-based analysis links the 20% add-on to treatment intensity or outcomes. Association (the incentive existed and was publicly acknowledged) is not proof of altered care. On the self-pay labeling question: CMS's EMTALA page confirms Section 1867 of the Social Security Act obligates Medicare-participating hospitals to provide a medical screening examination and stabilizing treatment regardless of ability to pay, which constrains but does not eliminate downstream effects of self-pay coding; no evidence was found that self-pay coding changed COVID treatment decisions.admindisplayed2026-10-08T23:52:30.459Z [Submit evidence for or against this claim](/submit?claim=payment-incentives) Want to hear what's next for Haygood Health? Email me about it Add my name and number (optional) No spam. One email when there is something to show, and you can reply to a real person.